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Naïve	   embryonic	   stem	   cells	   (ESCs)	   hold	   great	   promise	   for	   research	   and	  
therapeutics	   as	   they	   have	   broad	   and	   robust	   developmental	   potential.	  	  
While	   such	   cells	   are	   readily	   derived	   from	  mouse	   blastocysts	   it	   has	   been	  
impossible	   to	   easily	   isolate	   human	   equivalents1,2,	   although	   human	  naïve-­‐
like	   cells	   have	   been	   artificially	   generated	   (rather	   than	   extracted)	   by	  
coercion	   of	   human	   primed	   ES	   cells	   by	  modifying	   culture	   conditions2-­‐4	   or	  
through	   transgenic	   modification5.	   Here	   we	   show	   that	   a	   sub-­‐population	  
within	  cultures	  of	  human	  ESCs	  (hESCs)	  and	  induced	  pluripotent	  stem	  cells	  
(hiPSCs)	  manifest	  key	  properties	  of	  naïve	  state	  cells.	  These	  naïve-­‐like	  cells	  
can	  be	  genetically	  tagged,	  and	  are	  associated	  with	  elevated	  transcription	  of	  
HERVH,	  a	  primate-­‐specific	  endogenous	  retrovirus	  (ERV).	  HERVH	  elements	  
provide	   functional	   binding	   sites	   for	   a	   combination	   of	   naïve	   pluripotency	  
transcription	   factors,	   including	   LBP9,	   recently	   recognized	   as	   relevant	   to	  
naivety	   in	   mice6.	   LBP9/HERVH	   drives	   hESC-­‐specific	   alternative	   and	  
chimeric	   transcripts,	   including	   pluripotency	   modulating	   long	   non-­‐coding	  
RNAs	   (lncRNAs).	   Disruption	   of	   LBP9,	   HERVH	   and	   HERVH-­‐derived	  
transcripts	   compromises	   self-­‐renewal.	   These	   observations	   define	   HERVH	  
expression	  as	  a	  hallmark	  of	  naïve-­‐like	  hESCs,	  and	  establish	  novel	  primate-­‐
specific	  transcriptional	  circuitry	  regulating	  pluripotency.	  	  While	   many	   genes	   are	   involved	   in	   pluripotency,	   transposable	   element	   (TE)	  transcription,	   particularly	   involving	   ERVs,	   has	   wired	   different	   genes	   into	   the	  network	   in	   humans	   and	   mice7.	   Given	   a	   role	   for	   ERVs	   in	   pluripotency8-­‐10,	   we	  surveyed	  RNAseq	  data	  of	  human	  pluripotent	  stem	  cells	   (hPSCs),	  notably	  hESCs	  and	  hiPSCs	  finding	  that	  several	  TEs	  are	  expressed	  at	  higher	  levels	  in	  hPSCs,	  ERV1	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type	   of	   long	   terminal	   repeat	   (LTR)	   retroelements	   being	   foremost,	   of	   which	  HERVH	  was	   the	  most	  highly	   expressed8,11	   (Figs.	   1a-­‐b,	   E1a-­‐b).	  Uniquely	   aligned	  reads	  (Table	  S6)	  indicate	  that	  550	  of	  the	  1225	  full-­‐length	  HERVH	  genomic	  copies	  are	   transcribed	   in	   hPSCs	   (Figs.	   E1c-­‐d;	   Table	   S7).	   Raised	   transcription	   was	  associated	   with	   elements	   containing	   consensus	   LTR7	   rather	   than	   diverged	  variants	  (LTR7B/C/Y:	  Table	  S7).	  Lower	  expression	  of	  other	  ERVs	  (Fig.	  1b)	  was	  confirmed	  via	  qRT-­‐PCR	  (Fig.	  1c).	  We	  focused	  on	  HERVH	  as	  this	  was	  the	  only	  one	  detected	  by	  qRT-­‐PCR	   in	  all	  hiPSC	   lines	  analysed	  (Fig.	  1c).	  Results	  are	  robust	   to	  use	  of	  reads	  that	  map	  to	  more	  than	  one	  location	  (Table	  S16).	  	  To	  address	  how	  specific	  HERVH	  transcription	  is	  to	  hPSCs	  we	  compared	  RNAseq	  datasets	  of	  hPSCs	  and	  multiple	  differentiated	  cells	  and	  tissues	  (Fig.	  E1c;	  Tables	  S4,	  S5,	  S7).	  In	  agreement	  with	  our	  hiPSC	  data,	  HERVH	  transcription	  was	  highest	  in	  hPSC	  lines.	  The	  majority	  of	  the	  transcribed	  loci	  are	   identical	  between	  hiPSCs	  and	   hESCs	   (Figs.	   E1c-­‐d).	   HERVH	   transcription	   levels	   are	   much	   lower	   in	   both	  differentiated	  cells	  and	  cancer	  cell	  lines	  (Fig.	  E1c).	  	  	  	  HERVH	   transcription	   levels	   are	   higher	   in	   hiPSCs	   at	   early	   passages	   following	  reprogramming	  (Fig.	  1d),	  indicating	  that	  the	  reprogramming	  process	  itself	  might	  induce	   HERVH	   expression.	   At	   later	   passages	   the	   transcription	   of	   HERVH	   in	  hiPSCs	  approaches	  hESC	  levels.	  	  	  Consistent	   with	   HERVH	   transcription	   in	   hPSCs,	   ChIP-­‐seq	   data	   show	   that,	   in	  contrast	   to	   HERVK	   and	   inactive	   HERVHs,	   active	   HERVHs	   are	   marked	   with	  transcriptionally	   active	  histone	  marks11,12	   (H3K4me1/2/3,	  H3K9ac,	  H3K36me3	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and	   H3K79me2),	   while	   the	   repressive	   marks	   (H3K9me3	   and	   H3K27me3)	   are	  rare,	   indicating	   functioning	   as	   active	   promoter/enhancers	   (Figs.	   2a,	   E2a-­‐e).	  Notably,	  active	  HERVHs	  are	  also	  enriched	  with	  binding	  sites	  of	  the	  pluripotency	  regulators/modifiers	   CHD113	   and	   Myc/Max14	   (Figs.	   E2b-­‐c;	   Table	   S15).	   HERVH	  activation	  is	  also	  inversely	  correlated	  with	  the	  DNA	  methylation	  status	  of	  LTR7	  of	  HERVH,	  as	  evidenced	  by	  hypomethylation	   in	  active	  LTR7	  regions	   in	  hPSCs15	  (Fig.	  E2f).	  	  To	  determine	  whether	  HERVH	  is	  a	  direct	  target	  of	  core	  pluripotency–associated	  transcription	   factors	   (TFs)	  we	   interrogated	  HERVH	   in	  hESC_H1	  ChIP-­‐Seq	  data3.	  This	   identified	  NANOG	  and	  OCT4	  (Fig.	  E3a).	  A	  candidate	  KLF4	  binding	  site	  was	  also	   identified	  within	  HERVH’s	   LTR	   (Fig.	   2b).	  We	   additionally	   asked	  which	   TF	  motifs	   are	   significantly	   enriched	   across	   four	   in	   silico	   tests	   (Fig	   E3b).	   Only	   one,	  LTR-­‐binding	  protein	  9	  (LBP9)	  –	  alias	  murine	  Tfcp2l1	  -­‐	  was	  significant	  across	  all	  analyses	   (Fig.	   E3b).	   Tfcp2l1	   is	   within	   the	   Oct4	   interactome16	   and	   binds	  regulatory	  regions	  of	  Oct4	  and	  Nanog17	  in	  mESCs.	  	  LBP9’s	  direct	  binding	  to	  LTR7	  is	   confirmed	   by	   ChIP-­‐qPCR	   and	   EMSA	   (Fig.	   2c,	   and	   Fig.	   E3c).	   	   EMSA	   further	  demonstrates	  LBP9/NANOG	  cooperation	   in	  binding	  LTR7	   (Fig.	  E3c),	   consistent	  with	   synergy	   following	   simultaneous	  over-­‐expression	   (Fig.	  E7c).	   	   LBP9-­‐specific	  binding	  was	  also	  detected	  in	  the	  5’-­‐region	  of	  NANOG	  (Fig.	  2c).	  	  	  
In	  vitro	  differentiation	  assays	  show	  that	  HERVH	  transcription	  levels	  decline	  over	  time	  in	  parallel	  with	  declines	  in	  OCT4,	  NANOG	  and	  LBP9	  (Fig.	  E3d),	  suggesting	  a	  role	   in	   HERVH	   expression.	   As	   expected,	   ectopic	   expression	   of	   LBP9,	   OCT4,	  NANOG	   and	   KLF4	   activated	   the	   pT2-­‐LTR7-­‐GFP#2	   reporter	   and	   enhanced	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endogenous	   HERVH	   transcription	   levels	   in	   human	   primary	   fibroblast	   (HFF-­‐1),	  while	  overexpression	  of	  c-­‐MYC	  or	  SOX2	  had	  no	  effect	  (Fig.	  2d,	  E7c).	  Conversely,	  a	  complementary	   ‘loss	  of	   function’	  RNAi	  assay	   in	  hESCs_H9	  revealed	  that	  HERVH	  transcription	   levels	   were	   reduced	   following	   OCT4,	   NANOG	   and	   LBP9,	   but	   not	  SOX2,	  knockdown	  (KD)	  (Figs.	  2e-­‐f).	  	  	  We	   confirmed	   that	   LBP9	   directly	   stimulates	   HERVH-­‐driven	   expression,	   by	  comparing	   in	   hiPSCs	   signals	   of	   a	   wild-­‐type	   (WT)	   pT2-­‐LTR7-­‐GFP#1	   reporter	  construct	  and	  a	  mutant	  lacking	  the	  LBP9	  motif	  (ΔLBP9:	  Fig.	  E7d).	  When	  WT	  and	  mutant	   constructs	   were	   transfected	   into	   hiPSCs,	   the	   GFP	   signal	   was	   clearly	  detected	   from	   the	  WT	   reporter,	   but	   it	  was	   decreased	   by	   2-­‐fold	   in	   ΔLBP9	   (Fig.	  E7d).	  	  	  ESC-­‐specific	   TFs	   OCT4,	   NANOG,	   KLF4	   and	   LBP9	   thus	   drive	   transcription	   in	  hPSCs.	   In	  contrast	  to	  mice	   in	  which	  LBP9	  binding	  sites	  are	  genomically	  distinct	  from	   those	  other	  pluripotency	  TFs6,	   the	  key	  pluripotent	  TFs	   cluster	  within	   the	  primate-­‐specific	  HERVH	  (Fig.	  2b).	  	  
	  To	   test	   the	   functional	   importance	   of	   HERVH,	   we	   analysed	   RNAseq	   data	   to	  investigate	   the	   influence	   of	   LTR7/HERVH	   on	   the	   expression	   of	   neighbouring	  regions.	   	   We	   find	   that	   LTR7	   initiates	   chimeric	   transcripts,	   functions	   as	   an	  alternative	   promoter	   or	   modulates	   RNA	   processing	   from	   a	   distance	   (Figs.	   3a,	  E4b;	   Tables	   S8-­‐9).	   128	   and	   145	   chimeric	   transcripts	  were	   identified	   in	   hiPSCs	  and	   hESCs,	   respectively	   (Fig.	   E4a;	   Tables	   S8,-­‐9).	   One	   gene	   can	   contribute	   to	  multiple	   chimeric	   transcripts.	   The	   chimeric	   transcripts	   between	   HERVH	   and	   a	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downstream	   gene	   generally	   lack	   the	   5’	   exon(s)	   of	   the	   canonical	   version	   (e.g.	  SCGB3A2)	   while	   part	   of	   HERVH/LTR7	   is	   exonized	   (e.g.	   RPL39L)	   (Fig	   3a).	   A	  significant	  fraction	  of	  HERVH	  sequence	  can	  be	  incorporated	  into	  novel,	   lineage-­‐specific	   genes	   (e.g.	   ESRG:	   Fig.	   3a)	   or	   lncRNAs	   (e.g.	   RP11-­‐69I8.2:	   Fig.	   E4d	   and	  Table	  S10).	  We	  confirmed	  several	  hPSC	  specific	  chimeric	  transcripts	  by	  RT-­‐PCR	  (Fig.	  3a).	  Transcriptional	  start	  signals	  commonly	  map	  to	  HERVH-­‐LTR	  boundary	  regions	   (Fig.	   E4c).	   Unlike	   the	   chimeric	   transcripts	   the	   canonical	   genes	   are	  commonly	  not	  expressed	  in	  pluripotent	  cells.	  	  	  Nearly	  10%	  of	  the	  transcripts	  driven	  off	  HERVH	  are	  annotated	  as	  lncRNA12	  (see	  Table	   S11	   for	   coding	   potential).	   54	   transcripts	   were	   identified	   that	   are	  commonly	  detected	  in	  hPSCs,	  while	  the	  rest	  were	  sporadic	  (Fig.	  E4d).	  The	  former	  set	   includes	   linc-­‐ROR	   and	   linc00458,	   known	   to	   modulate	   pluripotency18,19.	  Alignment	  of	  the	  22	  most	  highly	  expressed	  transcripts	  reveals	  an	  LTR7/HERVH-­‐derived	  conserved	  core	  domain	  (CD)	  (Fig.	  E4f).	  The	  domain	  is	  predicted	  to	  bind	  RNA-­‐binding	   proteins,	   including	   pluripotency	   factors	   (e.g.	   NANOG)	   and	  pluripotency-­‐associated	   histone	  modifiers	   (e.g.	   SET1A	   and	   SETDB1)	   (Fig.	   E4g).	  In	   agreement	   with	   a	   role	   in	   pluripotency,	   linc00458	   physically	   interacts	   with	  SOX219.	  
	  To	  explore	  the	  effect	  of	  either	  LBP9	  or	  specific	  HERVH-­‐derived	  transcripts	  on	  the	  reprogramming	  process,	  we	  asked	  whether	  forced	  expression	  of	  LBP9,	  ESRG	  or	  the	   conserved	   domain	   of	   lncRNAs	   (LTR7-­‐CD)	   modulates	   the	   fibroblast-­‐hiPSC	  transition.	   While	   the	   overexpressed	   gene	   products	   affect	   neither	   pluripotency	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nor	   self-­‐renewal	   (Figs.	   E5a-­‐b),	   all	   facilitate	   reprogramming	   by	   accelerating	   the	  mesenchymal-­‐epithelium	  transition	  or	  hiPSC	  maturation	  (Figs	  3b,	  E5c).	  	  	  While	   LBP9	   is	   key	   to	   the	  murine	  naïve	   state6,20,	  HERVH	   is	   primate-­‐specific.	   To	  determine	   whether	   HERVH/LBP9	   delineates	   a	   primate-­‐specific	   pluripotency	  circuitry,	  we	  performed	  “loss	  of	  function”	  experiments	  using	  small	  hairpin	  RNAs	  (shRNAs)	   against	   LBP9	   or	   HERVH	   (Figs.	   3c-­‐f,	   E5d-­‐g).	   	   Pluripotency-­‐associated	  TFs	   and	   markers	   are	   down-­‐regulated,	   while	   multi-­‐lineage	   differentiation	  markers	  are	  up-­‐regulated	  upon	  knockdown	  of	  either,	  but	  not	  in	  controls	  (Fig.	  3c-­‐d,	   E5f-­‐g).	   	   Depletion	   of	   LBP9	   or	   HERVH	   in	   hESCs	   thus	   results	   in	   loss	   of	   self-­‐renewal.	  Knockout	  of	  LBP9	  similarly	  abolishes	  hESC	  self-­‐renewal	  (Figs.	  E5h-­‐j).	  In	  contrast	  to	  hPSCs,	  the	  Tfcp2l1/LBP9	  knockdown	  in	  mESCs	  does	  not	  reduce	  levels	  of	  Oct4,	  Sox2	  and	  Nanog	  in	  serum-­‐based	  conditions	  (Fig.	  E5k)21,	  but	  only	  in	  2i6.	  In	   fact,	   Tfcp2l1/LBP9	   does	   not	   affect	   self-­‐renewal,	   but	   rather	   differentiation	  potential	  (Fig.	  E5k).	  	  	  Genome-­‐wide	   gene	   expression	   patterns	   are	   highly	   similar	   between	   LBP9	   and	  HERVH	   knockdowns	   (Fig.	   3e),	   consistent	   with	   LBP9	   regulating	   HERVH-­‐driven	  expression.	   1094	   of	   the	   2627	   genes	   are	   similarly	   regulated	   in	   LBP9/HERVH	  knockdowns	   (Fig.	   3f;	   Table	   S12).	   While	   some	   HERVH-­‐derived	   chimeric	  transcripts	  are	  potentially	  directly	  affected	  by	  depletion	  of	  HERVH	  (Tables	  S13-­‐14),	  qRT-­‐PCR	  identifies	  19	  HERVH-­‐derived	  lncRNAs,	  down-­‐regulated	  in	  response	  to	  both	  HERVH	  and	  LBP9	  knockdowns	  (Fig.	  E4e).	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While	   several	   of	   the	   differentially	   expressed	   genes	   are	   associated	  with	  murine	  pluripotency,	   the	   LBP9/HERVH-­‐driven	   list	   of	   transcripts	   defines	   a	   primate-­‐specific	   pluripotency	   network.	   Our	   analyses	   defined	   two	   classes	   of	   genes,	   (I)	  those	  conserved	  between	  mouse	  and	  human	  that	  contribute	  to	  the	  pluripotency	  in	   both,	   and	   (II)	   a	   primate-­‐specific	   group	   that	   includes	   (a)	   those	   with	   an	  orthologous	  partner,	  but	  are	  not	  involved	  in	  murine	  pluripotency	  and	  (b)	  novel	  (not	  in	  mouse)	  transcripts	  (Figs.	  E4b,	  E4d).	  Several	  HERVH	  elements	  in	  class	  IIa	  affect	  gene	  expression	  in	  cis,	  and	  drive	  specific	  genic	  isoforms	  (e.g.	  SCGB3A2).	  A	  subset	   of	   class	   IIb	   contains	   HERVH-­‐derived	   novel	   sequences	   (e.g.	   linc-­‐ROR,	  linc000548,	  ESRG)	  (Fig.	  E4d).	  	  	  	  We	  examined	  one	  class	  IIb	  transcript	  in	  detail.	  ESRG	  has	  a	  putative	  open	  reading	  frame	   (ORF)	   only	   in	   human	   (Fig.	   E6a;	   Supplementary	  Data	   1),	   and	   is	   uniquely	  expressed	   in	   human	   inner	   cell	  mass	   (ICM)	   and	  PSCs	   (Fig.	   E6b).	   Knockdown	  of	  ESRG	   compromised	   self-­‐renewal	   of	   hESCs,	   as	   many	   pluripotency-­‐associated	  genes	  were	  decreased,	  while	  SOX2	  expression	  was	  slightly	  elevated	  (Figs.	  E6c-­‐e).	  The	   KD-­‐ESRG	   colonies	   lost	   their	   hESC	   morphologies	   and	   committed	   to	  differentiation	   (Figs.	   E6e-­‐f).	   Expression	   of	   ESRG	   along	   with	   the	   OSKM	  pluripotency	   factors	   has	   a	   similar	   effect	   on	   the	   reprogramming	   process	  compared	  with	   LBP9	   (Fig	   E5c).	   ESRG	   is	   thus	   an	  HERVH-­‐associated	   novel	   gene	  required	   for	  human-­‐specific	  pluripotency,	  with	  a	  more	  specific	  phenotype	   than	  upstream	  regulators.	  	  	  Given	  that	  the	  naïve-­‐associated	  TFs	  together	  cluster	  on	  HERVH	  and	  the	  HERVH-­‐derived	   products	   are	   essential	   for	   primate	   pluripotency,	   we	   asked	   whether	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HERVH-­‐driven	   transcription	   marks	   the	   naïve-­‐like	   stage	   in	   hPSC	   cultures.	   	   To	  explore	   this	   the	   reporter	   construct,	   pT2-­‐LTR7-­‐GFP#2	   was	   integrated	   into	   the	  genome	  of	  either	  mouse	  or	  human	  PSCs	  (Figs.	  4a,	  E7a-­‐b,	  E8i)	  by	  Sleeping	  Beauty	  gene	   transfer,	   providing	   stable	   transgene	   expression22.	   While	   all	   of	   mESC	  colonies	  homogeneously	  express	  GFP	  (Fig	  E7a),	  only	  ~4%	  of	  cells	   in	  each	  hESC	  colony	   show	   a	   strong	  GFP	   signal	   (GFP(high)),	   indicating	   cellular	   heterogeneity	  (Figs.	   E7e,	   E7h-­‐j).	   The	   fraction	   either	   weakly	   or	   unexpressing	   GFP	   we	   term	  GFP(low)	  and	  GFP(-­‐)	  respectively	  (Fig	  4a,	  E7b,	  E7e).	  RNAseq	  data	  of	  hESCs	  from	  single	   cells23,24	   and	   hPSC	   lines	   confirm	   that	   pluripotent	   cultures	   exhibit	  variability	   in	   HERVH	   expression	   (Fig.	   E1d),	   indicating	   that	   the	   GFP(high)	  subpopulation	  may	  differ	   from	  the	  GFP(low)	  subpopulations.	  Consistent	  with	  a	  naïve-­‐like	   state,	   data	   mining	   of	   single	   cell	   RNAseq	   datasets24	   reveals	   that	   the	  expression	   level	   of	   HERVH	   in	   hESCs	   is	   correlated	   with	   several	   pluripotency-­‐associated	  genes,	  including	  naïve-­‐associated	  TFs	  (Fig.	  E1e).	  	  	  	  To	  collect	  uniform	  GFP(high)	  and	  GFP(low)	  hPSCs,	  we	  performed	  two	  rounds	  of	  FACS	   (Fig.	   4a).	   We	   first	   sorted	   GFP(+)	   cells	   that	   were	   further	   divided	   into	  GFP(high)	   and	   GFP(low)	   categories.	   Strikingly,	   GFP(high)	   cells	   are	   capable	   of	  forming	   tight,	   uniformly	   expressing	   3D	   colonies	   characteristic	   of	   naïve	  mESCs	  (Fig.	  4a;	  Supplementary	  Video	  S1).	  In	  contrast,	  GFP(low)	  cells	  form	  flat	  colonies,	  resembling	   mouse	   epiblast	   stem	   cells	   (mEpiSCs)	   (Fig.	   4a).	   We	   also	   observed	  mosaic	   colonies.	   Immunostaining	   of	   3D	   and	   chimeric	   colonies	   reveals	   that	   the	  NANOG	  and	  GFP(high)	  signals	  copresent	  (Supplementary	  Videos	  S1-­‐2).	  Thus,	  the	  GFP(high)	  subpopulation	  in	  human	  pluripotent	  stem	  cells	  are	  enriched	  for	  cells	  resembling	  the	  murine	  naïve/ground	  state.	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  To	   examine	   this	   possibility,	   GFP(high)	   vs	   GFP(low)	   cells	   were	   subjected	   to	  expression	   analyses.	   qRT-­‐PCR	   revealed	   significant	   up-­‐regulation	   of	   naïve-­‐associated	   TFs4-6	   and	   down-­‐regulation	   of	   lineage-­‐commitment	   genes	   in	  GFP(high)	   vs	   GFP(low)	   (Fig.	   4b).	   As	   in	   naïve	   mESCs25	   and	   human	   ICM26	   X	  chromosomes	   are	   activated	   in	   GFP(high)	   hESCs_H9,	   as	   evidenced	   by	   nearly	  complete	   loss	   of	   condensed	  H3K27me3	   nuclear	   foci	   (Fig.	   4d)	   and	   low	   level	   of	  XIST	  expression	  (Fig	  4c).	  However,	  nearly	  60%	  GFP(low)	  hESCs	   transited	   from	  GFP(high)	  hESCs	  	  are	  marked	  with	  condensed	  H3K27me3	  foci	  or	  higher	  density	  of	   H3K27me3	   in	   the	   nucleus	   (Figs.	   4d,	   E8g).	   These	   data	   are	   consistent	  with	   a	  naïve-­‐like	  state	  for	  GFP(high)	  cells	  and	  a	  primed	  state	  for	  GFP(low)	  cells	  (one	  X	  chromosome	  inactivated	  or	  in	  process	  of	  being	  inactivated).	  	  GFP(high)	  cells	  can	  be	  maintained	  in	  the	  modified	  2i/LIF	  medium	  for	  a	  long	  time,	  with	  higher	  single-­‐cell	  clonality	  as	  well	  as	  full	  pluripotency	  (Fig.	  E8a-­‐d).	  However,	  GFP(high)	   and	   GFP(low)	   cells	   have	   slightly	   different	   differentiation	   potential.	  When	   differentiation	   triggered,	   certain	   naïve-­‐associated	   TFs	   are	  maintained	   at	  higher	   levels	   in	   GFP(high)	   naïve-­‐like	   cells	   compared	   with	   GFP(low),	   and	   start	  their	   differentiation	   program	   with	   a	   delay	   (Figs.	   E8e-­‐f).	   Early	   passage	   hPSC	  cultures	  behave	  somewhat	  similarly	  to	  GFP(high)	  cells	  (Figs.	  E9a-­‐c).	  	  Transcriptomes	   of	   GFP-­‐sorted	   cell	   populations	   and	   previously	   characterized	  naive-­‐like	   and	   primed	   hPSCs4	   and	  mouse	   counterparts	   as	  well	   as	   human	   ICM,	  support	  a	  naive-­‐like	  status	  of	  GFP(high)	  cells.	  Unbiased	  hierarchical	  clustering	  of	  the	  expression	  profiles	  revealed	  that	  GFP(high)	  and	  GFP(+)	  cells	  have	  a	  similar,	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but	  non-­‐identical,	  expression	  pattern,	  one	  that	  sharply	  contrasts	  with	  GFP(low)	  (Fig.	  E8h).	  Strikingly,	  GFP(high)	  and	  GFP(+)	  samples	  clustered	  with	  human	  ICM	  and	   the	   published	   naïve-­‐like	   hPSCs,	   respectively	   (Fig.	   4e).	   Importantly,	  GFP(high)	  cells	  cluster	  closest	  to	  human	  ICM	  (Fig.	  4e).	  	  	  Cross-­‐species	   comparison	   of	   expression	   of	   9,583	   mouse–human	   orthologs	  revealed	  that	  GFP(high)	  and	  GFP(+)	  correlated	  to	  published	  naïve	  hPSCs,	  while	  GFP(low)	  clustered	  with	  primed	  cells	  (Figs.	  4f-­‐g),	  supporting	  the	  significance	  of	  HERVH-­‐driven	  transcription	  defining	  a	  naïve-­‐like	  state.	  	  To	  address	  how	  gene	  expression	  changes	  up	  to	  the	  ICM	  stage,	  we	  analysed	  114	  RNAseq	   samples	   harvested	   in	   early	   developmental	   stages	   of	   embryogenesis24	  and	   3	   RNAseq	   samples	   of	   naïve-­‐like	   hESCs	   (3iL_hESC3).	   HERVH	   expression	  appears	   already	   in	   the	   zygote,	   but	   the	  pattern	  of	   activated	   loci	   changes	  during	  early	   development	   (Figs.	   E9d-­‐e).	   Importantly,	   the	   pattern	   of	   active	   loci	  characteristic	  of	  ICM	  is	  the	  closest	  to	  naïve-­‐like	  hESCs,	  including	  GFP(high)	  (Fig.	  E9d).	  Notably,	  the	  number	  of	  activated	  HERVH	  loci	  is	  particularly	  high	  in	  hESCs,	  especially	  in	  naïve-­‐like	  cells	  and	  marked	  with	  H3K4me3	  (Figs.	  E9d-­‐f),	  indicating	  that	  HERVH	  may	  play	  some	  roles	  in	  the	  derivation	  and/or	  maintenance	  of	  naïve-­‐like	  hPSCs.	  	  	  To	   address	   how	   HERVH-­‐driven	   gene	   expression	   modulates	   pluripotency,	   we	  surveyed	  differentially	  regulated	  genes	  in	  GFP(high)	  vs	  GFP(low),	  intersected	  by	  HERVH	   cis-­‐regulation.	   The	   differentially	   regulated	   genes	   located	   in	   the	  neighbourhood	   (+/-­‐50	   kb)	   of	   HERVH	   display	   a	   similar	   expression	   pattern	   to	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those	  differentially	  expressed	  in	  GFP(high)	  vs	  GFP(low)	  and	  in	  human	  naïve-­‐like	  vs	   primed	   stages,	   derived	   under	   specific	   culture	   conditions4	   (Fig.	   E9h).	   In	  contrast,	  a	  distinct	  pattern	  is	  observed	  when	  comparing	  mESCs	  vs	  mEpiSCs	  (Fig.	  E9g).	  Strikingly,	  there	  is	  an	  inverse	  pattern	  of	  expression	  between	  genes	  defining	  naïve-­‐like	   stage	   [up	   in	   GFP(high)	   vs	   GFP(low)]	   and	   those	   that	   are	   down-­‐regulated	  in	  HERVH	  knockdowns	  (rho=-­‐0.6,	  P<<0.0001;	  Fig.	  E9i),	  underlying	  the	  significance	  of	  HERVH	  in	  regulating	  the	  naïve-­‐like	  state	  in	  humans.	  Differentially	  expressed	  genes	  between	  GFP(high)	  vs	  GFP(low)	  populations	  were	  enriched	  for	  Gene	   Ontology	   (GO)	   terms	   of	   developmental	   processes,	   morphogenesis	   and	  organismal	  processes	   (Fig.	  E9j).	  Transition	  of	  naïve-­‐like	   cells	   into	  primed	   state	  following	  depletion	  of	  HERVH	  supports	  the	  above	  conclusion	  (Fig	  E9k).	  	  While	  GFP(high)	   cells	  have	  many	  properties	   resembling	  naïve	  mESCs,	   they	  are	  better	   regarded	   as	   being	   naïve-­‐like,	   not	   least	   because	   it	   is	   unclear	   that	   human	  and	   naïve	   mESCs	   need	   be	   identical.	   Indeed,	   while	   LBP9	   is	   associated	   with	  pluripotency6,20	  in	  mammals,	  HERVH	  was	  recruited	  to	  the	  pluripotency	  network	  exclusively	   in	  primates.	  How	  then	  to	  define	  naïve	  human	  pluripotency	   if	  we	  do	  not	   necessarily	   expect	   them	   to	   be	   identical	   to	  mouse	   ones?	   	  We	   suggest	   that,	  rather	  than	  hard	  to	  replicate	   inter-­‐species	  chimaera	  experiments27,	   the	  optimal	  approach	   is	   to	   define	   cells	   by	   similarity	   of	   expression	   to	   the	   ICM	   (see	  Supplementary	  Discussion).	   	   In	   this	   regard	  GFP(high)	   cells	   are	   one	   of	   the	   best	  current	  models	  of	  naïve-­‐like	  status.	  	  	  That	   LBP9	   forms	   heteromer	   complexes	   functioning	   either	   as	   a	   transcriptional	  activator	  or	  a	  repressor,	  depending	  upon	  the	  partner28	  is	  consistent	  with	  HERVH	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being	  recruited	  to	   the	  pluripotency	  network	  by	  serendipitous	  modification	  of	  a	  pluripotency	  factor	  detailed	  to	  defend	  the	  cell	  against	  it	  (Fig.	  E10).	  Whatever	  the	  origin,	   LTR7/HERVH	   is	   an	   efficient	   reporter	   for	   the	   naïve-­‐like	   state	   most	  probably	  because	  it	  acts	  as	  a	  platform	  for	  multiple	  key	  pluripotent	  transcription	  factors29.	  Similarly	  the	  LTR7-­‐GFP	  reporter	  should	  enable	  optimization	  of	  naïve-­‐like	  hPSC	  culture	  conditions.	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Figure	   1.	   HERVH	   is	   a	   specific	   marker	   of	   human	   pluripotent	   stem	   cells	  
(hPSCs)	  	  
a,	   Expression	   of	   various	   Transposable	   Elements	   (TEs)	   in	   human	   induced	  pluripotent	  stem	  cells	  (hiPSC),	  hESC	  (H1),	  and	  human	  fibroblast	  HFF-­‐1.	  Colours	  indicate	  different	  classes	  of	  TEs	  (red,	  long	  terminal	  repeat	  elements	  (LTR);	  green,	  long	   interspersed	   nuclear	   elements	   (LINE);	   blue,	   short	   interspersed	   nuclear	  elements	  (SINE);	  grey,	  other	  repeat	  elements).	  b,	  The	  proportion	  of	  active	  loci	  	  in	  each	  HERV	   family.	   c,	   Relative	  mRNA	   levels	   of	  HERV(H/K/W)	   in	   hESC	   (HES-­‐3),	  various	   hiPSCs	   lines	   and	   their	   parental	   somatic	   cells.	   d,	   Effect	   of	   long-­‐term	  culturing	   on	   HERVH	   transcription	   levels	   in	   hiPSCs	   generated	   from	   HFF-­‐1.	   P,	  passage	   number.	   c,	  d,	   mRNA	   levels	   are	   normalized	   to	   GAPDH,	   and	   relative	   to	  HES-­‐3.	  Error	  bars,	  s.d.	  (n=3	  independent	  cell	  cultures),	  t-­‐test,	  *P<0.05.	  	  
Figure	  2.	  HERVH	  is	  recruited	  into	  the	  circuitry	  of	  human	  pluripotency	  	  
a,	   The	   distribution	   of	   H3K4me3	   and	   H3K9m3	   in	   active	   vs	   inactive	   HERVH	  regions	  in	  hiPSCs,	  hESCs	  and	  HFF-­‐1.	  b,	  Conserved	  binding	  sites	  of	  OCT4,	  NANOG,	  LBP9	   and	   KLF4	   are	   shown	   in	   active	   LTR7s	   vs	   moderately	   active	   versions	   of	  LTR7Y/C.	  The	  Jaspar	  consensus	  sequence	  of	  the	  LBP9	  is	  shown.	  c,	  Confirmation	  of	  LBP9	  binding	  to	  LTR7	  by	  ChIP-­‐qPCR	  with	  two	  different	  primers	  (LTR7#1,	  #2)	  targeting	  LTR7	   regions.	  HERVH-­‐gag,	  HERVH-­‐pol	   and	  LTR5_Hs	   (LTR	  of	  HERVK)	  served	   as	   negative	   controls,	  while	   an	  upstream	   region	   of	  NANOG	   (7.5	   kb	   from	  TSS)	   was	   a	   positive	   control.	   Data	   are	   collected	   from	   two	   independent	  experiments	   with	   biological	   replicates	   per	   experiment	   (LBP9:	   n=3;	   IgG:	   n=2),	  error	  bars,	  s.d.;	  t-­‐test	  *P<0.05,	  **P<0.01.	  d,	  Upregulation	  of	  HERVH	  transcription	  in	  HFF-­‐1	   regulated	  by	  exogenous	  pluripotency-­‐associated	   transcription	   factors.	  Data	   are	   collected	   from	   three	   independent	   experiments	   with	   biological	  triplicates	  per	  experiment.	   e-­‐f,	  Effects	  of	  shRNA	  knockdowns	  of	  various	  TFs	  on	  HERVH	  and	  HERVK	  transcription	  in	  hESC_H9.	  Data	  shown	  are	  representative	  of	  three	   independent	   experiments	   with	   biological	   triplicates	   per	   experiment.	  d-­‐f,	  error	  bars,	  s.d.;	  t-­‐test	  *P<0.05,	  **P<0.01,	  P***<0.001.	  
	  
Figure	   3.	   HERVH	   triggers	   pluripotency-­‐regulating	   hPSC-­‐specific	   chimeric	  
transcripts	  and	  lncRNAs	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a,	   Expression	   of	   HERVH	   forces	   diversification	   of	   transcripts	   in	   hPSCs.	   Left:	  schematic	   representation	   of	   the	   HERVH-­‐derived	   alternative	   and	   chimeric	  transcripts.	   Right:	   RT-­‐PCR	   detects	   HERVH-­‐specific	   transcripts	   (marked	   by	  triangles)	  in	  hPSCs	  and	  NCR1	  in	  embryoid	  body	  (EB),	  but	  not	  in	  HFF-­‐1	  or	  K562.	  Yellow	  arrows	  indicate	  primer	  binding	  sites.	  b,	  The	  effects	  of	  LBP9	  and	  HERVH-­‐derived	   transcripts	   on	   reprogramming	   of	   HFF-­‐1	   to	   hiPSCs.	   Upper	   panel:	  Representative	  TRA-­‐1-­‐60	  stained	  wells	  are	  shown.	  	  Lower	  panel:	  The	  number	  of	  TRA-­‐1-­‐60+	  hiPS	  colonies	  reprogrammed	  from	  HFF-­‐1	  by	  LBP9,	  ESRG	  or	  LTR7-­‐CD	  in	  conjunction	  with	  OCT4,	  SOX2,	  KLF4	  and	  c-­‐MYC	  (OSKM).	  Error	  bars,	  s.d.,	  t-­‐test	  *P<0.05,	   **P<0.01	   from	  three	   independent	  experiments.	  c-­‐d,	  qRT-­‐PCR	  analyses	  to	   determine	   the	   relative	   expression	   level	   of	   pluripotency	   and	   differentiation	  markers	  after	  knockdown	  of	  LBP9	  (c)	  or	  HERVH	  (d)	  in	  hESC_H9.	  Data	  shown	  are	  representative	  of	   three	   independent	  experiments	  with	  biological	   triplicates	  per	  experiment.	   Error	   bars,	   s.d.,	   t-­‐test	   *P<0.05,	   **P<0.01,	   and	   ***P<0.001.	   ND,	   not	  detected.	   Representative	   immunostainings	   show	   the	   expression	   of	   PAX6	   and	  CDX2	  in	  LBP9	  and	  HERVH	  knockdowns	  (scale	  bar,	  100	  µm).	  e,	  Heat	  map	  showing	  genome-­‐wide	  gene	  expression	  in	  hESC_H9	  following	  knockdown	  of	  GFP	  (shGFP),	  LBP9	   (shLBP9)	   and	   HERVH	   (shHERVH).	   The	   knockdown	   effect	   of	   LBP9	   and	  HERVH	  are	  highly	  similar	  (rho	  from	  Spearman’s	  correlation).	  For	  list	  of	  affected	  genes,	   including	   direct	   targets	   of	   shHERVH	   see	   Tables	   S13	   and	   S14.	   f,	   Venn	  diagram	  shows	  that	  1094/2627	  genes	  are	  similarly	  affected	  by	  KD-­‐HERVH	  and	  KD-­‐LBP9	  (Table	  S12).	  	  
	  
Figure	  4.	  HERVH	  genetically	  marks	  naïve-­‐like	  hESCs	  
a,	  Experimental	  scheme	  for	  isolating	  naïve-­‐like	  hPSCs.	  pT2-­‐LTR7-­‐GFP#2-­‐marked	  hESC_H9	   were	   enriched	   by	   FACS-­‐sorting	   in	   multiple	   rounds	   and	   cultured	   in	  
conventional	   hESC	  medium	   and	   in	   2i/LIF	   medium,	   respectively.	   Scale	   bar,	   200	  
μm.	  See	  also	  Supplementary	  Videos	  S1	  and	  S2.	  b,	  qRT-­‐PCR	  analyses	  of	  multiple	  transcription	   factors	  and	  markers	   for	  naive	  and	  primed	  state	   in	  GFP(high)	  and	  GFP(low)	  cells,	  respectively.	  c,	  qRT-­‐PCR	  analysis	  of	  XIST	  in	  GFP(high),	  GFP(low)	  hESC_H9	  and	  human	  female	  fibroblasts	  (HLF).	  b,	  c,	  Error	  bars,	  s.d.;	  t-­‐test	  *P<0.05,	  **P<0.01,	   and	   ***P<0.001(n=3	   independent	   cell	   cultures).	   d,	   Representative	  confocal	   images	   obtained	   after	   immunostaining	   for	   H3K27me3	   on	   GFP(high),	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GFP(low),	  hESC_H9s	  and	  HLF.	   	  Scale	  bar,	  20	  µm.	  The	  proportions	  of	  H3K27me3	  foci(+)	  (triangles)	  and	  (-­‐)	  cells	  in	  each	  sample	  are	  shown	  in	  the	  histogram.	  Error	  bar,	   s.d..	  Data	  were	  obtained	   from	  100-­‐450	   cells	   counted	   from	   five	   images	  per	  sample.	   e,	   Global	   expression	   cluster	   dendrogram	   between	   GFP(high),	   GFP(+),	  GFP(low)	   hESCs_H9,	   human	   inner	   cell	   mass	   (ICM)	   and	   previously	   established	  human	  naïve	   and	  primed	   cell	   lines4.	  Approximately	  Unbiased	   (AU)	  probability,	  Bootstrap	   Probability	   (BP)	   values	   and	   edge	   numbers	   at	   P-­‐value	   less	   than	   0.01	  are	  shown.	  ICM	  clusters	  closest	  with	  GFP(high)	  –	  nodes	  7,9.	  f,	  Correlation	  matrix	  displaying	  the	  unbiased	  and	  pairwise	  comparison	  of	  mouse–human	  orthologous	  gene	   expression	   between	  GFP-­‐marked	   hESC_H9	   (this	   study,	   green)	   and	  mouse	  and	   human4	   naïve	   as	   well	   as	   primed	   PSCs.	   Color	   bar	   indicates	   Spearman	  correlation	   strength.	  g,	   Cluster	   analysis	   using	   the	   average	   distance	  method	   on	  the	   same	   dataset	   as	   in	   f.	   GFP(high),	   GFP(+)	   and	   GFP(low)	   cells	   in	   e-­‐g	   were	  collected	   from	   hESC_H9	   cells	   cultured	   in	   conventional	   human	   ESC	   medium	   by	  FACS-­‐sorting.	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